Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19(ARF)

Genes Chromosomes and Cancer

Volumn 19, Issue 1, 1997, Pages 52-54

  Liu, Ling ^a   Goldstein, Alisa M ^b   Tucker, Margaret A ^b   Brill, Herbert ^a   Gruis, Nelleke A ^c   Hogg, David ^a   Lassam, Norman J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b NATIONAL CANCER INSTITUTE   (United States)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CELL CYCLE; CHROMOSOME 9P; CHROMOSOME MAP; DISEASE ASSOCIATION; FAMILIAL CANCER; GENE MUTATION; HUMAN; MELANOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031000617     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2264(199705)19:1<52::aid-gcc8>3.0.co;2-%23     Document Type: Article

References (23)

1. Borg A, Johansson U, Johannson O, Hakansson S, Westerdahl J, Masback A, Olsson H, Ingvar C (1996) Novel germline p16 mutation in familial malignant melanoma in southern Sweden. Cancer Res 56:2497-2500.
2. Duro D, Bernard O, Della Valle V, Berger R, Larsen CJ (1995) A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11:21-29.
3. Goldstein AM, Tucker MA (1995) Genetic epidemiology of familial melanoma. Dermatol Clin 13: 605-612.
4. Goldstein AM, Dracopoli NC, Ho EC, Fraser MC, Kearns KS, Bale SJ, McBride OW, Clark WH, Jr. Tucker MA (1993) Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am J Hum Genet 52:537-550.
5. Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W, Frants RR (1995) Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet 10:351-335.
6. Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-lieta-induced cell cycle arrest. Nature 371:6494, 237-261.
7. Holland EA, Beaton SC, Becker TM, Grulet OM, Peters BA, Rizos H, Kefford KF, Mann GJ (1995) Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 11:2289-2294.
8. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nature Genet 8:15-21.
9. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Wilson JK, Kinzler KW, Vogelstein B (1994) Deletion of p16 and p15 genes in brain tumors. Cancer Res 54:6353-6358.
10. Kamb A (1995) Cell-cycle regulators and cancer. Trends Genet 11:136-140.
11. Kamh A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockett E, Day RS III, Johnson BE, Skolnick MH (1994a) A cell cycle regulator potentially involved in the genesis of many tumor types. Science 264:436-440.
12. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, et al. (1994b) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 8:23-26.
13. Liu L, Lassam NJ, Slingerland JM, Bailey D, Cole D, Jenkins R, Hogg D (1995) Germline mutation and protein dysfunction in a family with inherited melanoma. Oncogene 11:405-412.
14. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rolins BJ, Sidransky D (1995) A novel p16INK4A transcript. Cancer Res 55:2995-2997.
15. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM, et al. (1994) Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res 54:5269-5272.
16. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
17. Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, Serrano M, Hannon GJ, Beach D, Dracopoli NC (1995) Mutations associated with familial melanoma impair p16INK4 function. Nature Genet 10:114-116.
18. Reymond A, Brent R (1995) p16 Proteins from melanoma-prone families are deficient in binding to Cdk4. Oncogene 11:1173-1178.
19. Stone S, Dayananth P, Jiang P, Weuver-Feldhaus JM, Tavtigian SV, Cannon-Albright L, Kamb A (1995a) Genomic structure, expression and mutational analysis of the p15 (MTS2) gene. Oncogene 11:987-991.
20. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A (1995b) Complex structure and regulation of the p16 (MTS1) locus. Cancer Res 55:2988-2994.
21. Walker DJ, Nancarrow DJ, Walters MK, Palmer JM, Weber JL, Hayward NK (1994) Linkage analysis in familial melanoma kindreds to markers on chromosome 6p. Int J Cancer 59:771-775.
22. Walker GJ, Hussussian CJ, Flores JF, Glendening JM, Haluska FG, Dracopoli NC, Hayward NK, Fountain JW (1995) Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. Hum Mol Genet 4:1845-1852.
23. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC (1996) Germline mutations in the binding domain of CDK4 in familial melanoma. Nature Genet 12:97-99.